Derepression of pathological cardiac genes by members of the CaM kinase superfamily

被引：93

作者：

McKinsey, Timothy A. ^{[1
]}

机构：

[1] Myogen Inc Gilead Colorado Inc, Westminster, CO 80021 USA

来源：

CARDIOVASCULAR RESEARCH | 2007年 / 73卷 / 04期

关键词：

transcription; signaling; CaM kinase; histone deacetylase; chromatin;

D O I：

10.1016/j.cardiores.2006.11.036

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In response to pathologic stresses such as hypertension or myocardial infarction, the heart undergoes a remodeling process that is characterized by myocyte hypertrophy, myocyte death and fibrosis, resulting in impaired cardiac function and heart failure. Cardiac remodeling is associated with derepression of genes that contribute to disease progression. This review focuses on evidence linking members of the Ca2+/calmodulin-dependent protein kinase (CaMK) superfamily, specifically CaMKII, protein kinase D (PKD) and microtubule associated kinase (MARK), to stress-induced derepression of pathological cardiac gene expression through their effects on class Ha histone deacetylases (HDACs). (c) 2006 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.

引用

页码：667 / 677

页数：11

共 124 条

[1] Roles of cardiac transcription factors in cardiac hypertrophy [J].

Akazawa, H ;

Komuro, I .

CIRCULATION RESEARCH, 2003, 92 (10) :1079-1088

[2] Silent information regulator 2α, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes [J].

Alcendor, RR ;

Kirshenbaum, LA ;

Imai, S ;

Vatner, SF ;

Sadoshima, J .

CIRCULATION RESEARCH, 2004, 95 (10) :971-980

[3] Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo [J].

Antos, CL ;

McKinsey, TA ;

Frey, N ;

Kutschke, W ;

McAnally, J ;

Shelton, JM ;

Richardson, JA ;

Hill, JA ;

Olson, EN .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (02) :907-912

[4] Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors [J].

Antos, CL ;

McKinsey, TA ;

Dreitz, M ;

Hollingsworth, LM ;

Zhang, CL ;

Schreiber, K ;

Rindt, H ;

Gorczynski, RJ ;

Olson, EN .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (31) :28930-28937

[5] Role of the regulatory domain of protein kinase D2 in phorbol ester binding, catalytic activity, and nucleocytoplasmic shuttling [J].

Auer, A ;

von Blume, J ;

Sturany, S ;

von Wichert, G ;

Van Lint, J ;

Vandenheede, J ;

Adler, G ;

Seufferlein, T .

MOLECULAR BIOLOGY OF THE CELL, 2005, 16 (09) :4375-4385

[6] CaM kinase II selectively signals to histone deacetylase 4 during cardiornyocyte hypertrophy [J].

Backs, Johannes ;

Song, Kunhua ;

Bezprozvannaya, Svetlana ;

Chang, Shurong ;

Olson, Eric N. .

JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (07) :1853-1864

[7] EMK protein kinase-null mice: Dwarfism and hypofertility associated with alterations in the somatotrope and prolactin pathways [J].

Bessone, S ;

Vidal, F ;

Le Bouc, Y ;

Epelbaum, J ;

Bluet-Pajot, MT ;

Darmon, M .

DEVELOPMENTAL BIOLOGY, 1999, 214 (01) :87-101

[8] Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity [J].

Biernat, J ;

Wu, YZ ;

Timm, T ;

Zheng-Fischhöfer, QY ;

Mandelkow, E ;

Meijer, L ;

Mandelkow, EM .

MOLECULAR BIOLOGY OF THE CELL, 2002, 13 (11) :4013-4028

[9] Comprehensive proteomic analysis of human par protein complexes reveals an interconnected protein network [J].

Brajenovic, M ;

Joberty, G ;

Küster, B ;

Bouwmeester, T ;

Drewes, G .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :12804-12811

[10] The cardiac fibroblast: Therapeutic target in myocardial remodeling and failure [J].

Brown, RD ;

Ambler, SK ;

Mitchell, MD ;

Long, CS .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2005, 45 :657-687

← 1 2 3 4 5 6 7 8 9 10 →